CPC Scientific Inc.
Andy Yan has over 20 years of experience in business development. Andy is currently the Director of Business Development at CPC Scientific Inc. and has been in this role since May 2023. Prior to this, they held the same position at KACTUS from January 2023 to April 2023. From September 2017 to January 2023, they were the Director of Business Development at Bestzyme, a subsidiary of GenScript USA Inc. Before that, Andy worked at GenScript Corporation, where they served as the Assistant Director of US Molecular Biology from June 2011 to August 2017 and as an Account Manager from September 2004 to June 2011.
Andy Yan's education history includes a Doctor of Philosophy (Ph.D.) in Analytical Chemistry from The City College of New York and a Master of Science (MS) in Analytical Chemistry from Peking University. The chronological information provided does not indicate specific start or end years for either degree.
This person is not in any offices
CPC Scientific Inc.
1 followers
With over 20 years of experience, CPC Scientific is a global CRDMO specializing in peptides and oligonucleotides. Our integrated service model supports partners through critical drug development stages, focusing on late-phase, large-scale, and commercial production. We provide GMP-grade synthetic peptides, oligonucleotides, and peptide-oligonucleotide conjugates, plus a wide range of custom and catalog research products. Our FDA- and ICH-compliant GMP facility ensures regulatory support for IND, NDA, and global filings. We offer process and method development, validation, stability studies, and regulatory documentation to accelerate your program from clinical trials to market. With scalable capacity from milligrams to 100 kilograms, flexible infrastructure, and a robust supply chain, CPC Scientific delivers dependable, high-quality results at every phase, providing the expertise and speed to bring your peptide and oligonucleotide programs to successful commercial production.